 prognost variabl patient diffus large-cel lymphoma macop-b twenty-six patient diffus large-cel lymphoma methotrex leucovorin doxorubicin cyclophosphamid vincristin prednison bleomycin macop-b april june univari multivari analys overal surviv septemb end point independ neg predictor surviv presenc symptom involv lymph node extranod site variabl burden age variabl patient abil treatment variabl rel risk simpl predict formula approxim percentag chanc surviv year number predict variabl present predictor signific multivari analysi patient complet respons